Page last updated: 2024-11-04

ropinirole and Pulmonary Fibrosis

ropinirole has been researched along with Pulmonary Fibrosis in 2 studies

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"This review describes the pharmacologic and pharmacokinetic properties of selected DAs and relates these characteristics to clinical outcomes, with an emphasis on adverse events."2.43A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. ( Burger, E; Härtter, S; Kvernmo, T, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersohn, F1
Garbe, E1
Kvernmo, T1
Härtter, S1
Burger, E1

Reviews

1 review available for ropinirole and Pulmonary Fibrosis

ArticleYear
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
    Clinical therapeutics, 2006, Volume: 28, Issue:8

    Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced;

2006

Other Studies

1 other study available for ropinirole and Pulmonary Fibrosis

ArticleYear
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual

2009